StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.80−0.62 (-11.44%)

Close on Nov 16, 2026Market cap $60.28MP/E –Yield –

Neuraxis, INC grew revenue 65.2% to $5.32M over the twelve months to Jun 30, 2026. Free cash flow was -$6.46M. At the latest close the market valued the company at $60.28M.

Revenue
$5.32M
+65.2% vs. a year earlier
Operating income
-$7.68M
TTM Q2 2026
Free cash flow
-$6.46M
FY2025
EPS, diluted
-$0.79
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$60.28M
P/E ratio
–
Price to sales
11.34
Price to book
8.95
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$5.32M
Net income
-$7.68M
EPS, diluted
-$0.79
Free cash flow
-$6.46M
Book value per share
$0.56
Diluted shares
12M

Trading

Previous close
$5.42
Open
$5.30
Day's range
$4.71 – $5.42
Volume
521,424
Average volume (20 days)
138,860
52-week range
$2.21 – $9.33
RSI (14 days)
27.1
Volatility (1 year)
74.9%
Relative volume
4.23×

Market cap history

Month-end market cap since 2023, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 16, 2026. The S&P 500 is measured by the SPY fund.

PeriodNRXSS&P 500DifferenceNRXS per yearS&P 500 per year
1 month-37.7%-3.1%−34.6 pts
3 months-23.8%-4.5%−19.4 pts
Year to date+5.7%+9.4%−3.6 pts
1 year+105.1%+11.3%+93.8 pts
3 years+87.9%+70.4%+17.5 pts+23.4%+19.4%

Five years at a glance

Fiscal years 2021 to 2025 and trailing twelve months, USD

Revenue

$5.32M+65.2% YoY

Gross profit

$4.55M+66.6% YoY

Operating income

-$7.68M

Net income

-$7.68M

EPS, diluted

-$0.79

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases Neuraxis filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Neuraxis

Electromedical & Electrotherapeutic Apparatus

Neuraxis, Inc. is a medical technology company that develops neuromodulation therapies for chronic and debilitating conditions of the gastrointestinal digestive system caused by disorders of gut-brain interaction. Its primary offering is IB-Stim, a proprietary Percutaneous Electrical Nerve Field Stimulation medical device cleared by the FDA to treat functional abdominal pain associated with irritable bowel syndrome, functional dyspepsia, and related nausea symptoms in patients eight years of age and older. The company also offers the Rectal Expulsion Device, which evaluates rectal neuromuscular function and tests for rectal hypersensitivity in adults. Target customers include pediatric and adult patients treated by pediatricians, pediatric gastroenterologists, and trained healthcare providers in clinical settings.

Company profile, executives and history

Neuraxis stock: common questions

What is Neuraxis's stock price?

NRXS closed at $4.80 on Nov 16, 2026, down 11.44% on the day. Over the past 52 weeks it traded between $2.21 and $9.33.

What is Neuraxis's market cap?

Neuraxis was worth $60.28M at the close on Nov 16, 2026: the share price times the diluted shares outstanding.

What is NRXS's P/E ratio?

Neuraxis lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.79), so it has no meaningful P/E ratio.

How much revenue does Neuraxis make?

Neuraxis reported revenue of $5.32M for the twelve months to Jun 30, 2026, up 65.2% from a year earlier.

Does Neuraxis pay a dividend?

No. Neuraxis has not paid a cash dividend over the last twelve months.

How has NRXS stock performed over the past year?

Including dividends, NRXS returned +105.1% over the past year, against +11.3% for the S&P 500.

How many NRXS shares are sold short?

0M shares were sold short at the latest FINRA report, 6.04% of the float, or 4.4 days of average trading volume.

Who are Neuraxis's competitors?

Companies most similar to Neuraxis by business, industry and size include NMTC, NUWE, CV, ECOR, EBRCZ.

See a number that looks wrong?